• About
    • Research and Development
    • Board of Directors
    • Management Team
    • LipimetiX
    • Careers
    • Safe Harbor Statement
  • Contact Us
  • Investors
    • Filings
    • Annual Report
    • Corporate Governance
    • Events and Presentations
    • Analyst Coverage
Capstone Therapeutics

Press Release June 21, 2022

June 21, 2022 by Barbara Dunford

CAPSTONE HOLDING CORP. ANNOUNCES EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION BY MAJORITY SHAREHOLDER, BP PEPTIDES, LLC

Categories: Press Release | Permalink

Comments are closed.

← Previous Post
Next Post →

Connect With Us

  • @CapstoneTHX
  • Facebook
  • Google+
  • LinkedIn
  • The Chairman’s Blog
  • LipimetiX

Site Info

  • Legal Disclaimer
  • Outlook Web Access
  • Investors

Stock Ticker

  • Loading stock data...

Press Releases

Press Release August 28, 2023
\nCapstone Holding Corp. Announces CFO Change\n...
Press Release March 7, 2023
\nCapstone Therapeutics Corp. Announces Results of Annual Meeting\n...
Press Release June 21, 2022
\nCAPSTONE HOLDING CORP. ANNOUNCES EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION BY MAJORITY SHAREHOL...
Press Release December 2, 2021
\nCAPSTONE THERAPEUTICS CORP. ANNOUNCES RESULTS OF ANNUAL MEETING\n...
Press release November 12, 2021
\nThe Annual Meeting of Stockholders of Capstone Therapeutics Corp. will be held on Thursday, December 1, 2021\n...
Press Release April 6, 2021
\nCAPSTONE THERAPEUTICS CORP. ANNOUNCES TRANSACTION WITH DIAMOND PRODUCTS HOLDINGS, LLC\n...
Press Release March 31, 2020
\nCAPSTONE THERAPEUTICS ANNOUNCES OPERATING RESULTS FOR FISCAL 2020 – INCLUDING A CHANGE IN ITS DEFERRED TAX ...
Press Release February 18, 2021
\nCAPSTONE THERAPEUTICS ANNOUNCES RESULTS OF SPECIAL SHAREHOLDER MEETING, AND A LICENSE TRANSFER/ROYALTY AGREEM...
Press Release December 28, 2020
\nCapstone Therapeutics Announces Exercise of Secured Debt and Interest Conversion Option by BP Peptides, LLC a...
Press Release March 27th, 2020
\nCapstone Therapeutics Annouces Transaction With TotalStone LLC\n...
Copyright ©2023 Capstone Therapeutics. All rights reserved.
Top